Antibiotic | Concentration (Āµg/disc) | Zone of inhibition | % Difference | |
---|---|---|---|---|
Control (MeanāĀ±āSD) | Experimental (MeanāĀ±āSD) | |||
Imipenem | 10 | 29āĀ±ā2.82 | 30.5āĀ±ā0.70 | Non-significant |
Ciprofloxacin | 5 | 40āĀ±ā4.24 | 39.5āĀ±ā6.36 | |
Tobramycin | 10 | 29.5āĀ±ā0.70 | 29āĀ±ā2.82 | |
Moxifloxacin | 5 | 35.5āĀ±ā0.70 | 33āĀ±ā2.82 | |
Ofloxacin | 5 | 34āĀ±ā0 | 34.5āĀ±ā3.53 | |
Sparfloxacin | 5 | 33āĀ±ā1.4 | 31āĀ±ā5.65 | |
Levofloxacin | 5 | 38āĀ±ā1.41 | 36.5āĀ±ā2.12 | |
Norfloxacin | 10 | 34.5āĀ±ā0.70 | 33.5āĀ±ā2.12 | |
Co-Trimoxazole | 25 | R | R | |
Nalidixic acid | 30 | 15āĀ±ā10.6 | 15.5āĀ±ā0.70 | |
Augmentin | 30 | R | 10.5āĀ±ā0.70 | Resistance reversal |
Gatifloxacin | 5 | 34.65āĀ±ā0.49 | 34āĀ±ā1.41 | Non-significant |
Amikacin | 30 | 22āĀ±ā1.41 | 21.5āĀ±ā0.70 | |
Streptomycin | 25 | 13āĀ±ā0 | 18āĀ±ā1.41 | 38.46* |
Ceftriaxone | 30 | 25.5āĀ±ā2.12 | 23.5āĀ±ā3.53 | Non-significant |
Cefpodoxime | 10 | 25āĀ±ā0 | 25.5āĀ±ā0.70 | |
Colistin | 10 | 21.7āĀ±ā0.7 | 22āĀ±ā0.6 | |
Kanamycin | 30 | 18.2āĀ±ā1.06 | 21āĀ±ā1.41 | |
Gentamicin | 10 | 21.5āĀ±ā0.7 | 2.05āĀ±ā0.7 | |
Ticarcillin | 75 | 26.7āĀ±ā1.06 | 25.5āĀ±ā0.7 |